Prospective Ocular Imaging for Intracranial Pressure Evaluation
POICCP
1 other identifier
observational
160
1 country
1
Brief Summary
This is a prospectively recruiting, database development study collecting images and videos of the spontaneous venous pulsation at the back of people's eyes - this is a pulse one can see on examination of the back of the eye, originating from the blood vessels around the nerve that connects the eye to the brain (the optic nerve), and is present in most people who have normal pressure around the brain. However, in people with raised pressure in the brain, this pulse disappears as the pressure rises. Many things can cause the pressure around the brain to increase, including tumours, swellings and trauma. The investigators want to test if high-quality images and videos of this pulse, taken using both hand-held and larger, fixed-platform machines, can be used to train a software tool to automatically detect this pulse. The investigators want to collect these images and videos in 2 groups of patients: those with no known or suspected brain pressure problems, and those who are suspected to have raised pressure and/or are due to undergo measurement of the pressure around the brain, called lumbar punctures or intracranial pressure bolt monitoring. These tests to check the pressure around the brain are invasive - they involve inserting needles in the back or directly into the brain to measure the pressure, and carry risks. The value of these two groups of people will be to help train the software to reasonably say whether a pulse is present or absent and, hopefully, estimate what the pressure around the brain may be without the need for an invasive test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 15, 2025
CompletedFirst Posted
Study publicly available on registry
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedAugust 3, 2025
January 1, 2025
11 months
January 15, 2025
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
• To acquire a multimodal dataset of clinical data, OCT scans and high-quality SVP fundal images and videos, to help the development of automated tools to detect and quantify SVPs.
To acquire a multimodal dataset of clinical data, OCT scans and high-quality SVP fundal images and videos, to help the development of automated tools to detect and quantify SVPs.
From enrollment to last study visit (optional 3 additional visits within 12 months)
Secondary Outcomes (3)
• To determine participant recruitment rate within the time frame of recruitment
From study activation to end of study recruitment period, expected to be 12 months
To determine the screen failure rate within the timeframe of recruitment
From study activation to end of study recruitment period, expected to be 12 months
To determine the study withdrawal rate
From study activation to end of study recruitment period, expected to be 12 months
Study Arms (3)
Healthy control participants
Healthy control participants
Suspected raised intracranial pressure - due to undergo lumbar puncture
Suspected raised intracranial pressure - due to undergo lumbar puncture
Suspected raised intracranial pressure - due to undergo intracranial pressure monitoring
Suspected raised intracranial pressure - due to undergo intracranial pressure monitoring
Eligibility Criteria
Healthy controls compared to participants due to undergo lumbar puncture or intracranial pressure bolt monitoring
You may qualify if:
- Aged ≥18 years
- Presumed normal ICP undergoing routine mydriatic ophthalmology OCT scans.
You may not qualify if:
- Significant media opacity restricting acquisition of retinal vein imaging and video capture in both eyes.
- Current or previous evidence of glaucoma, glaucoma suspect, family history of glaucoma in a 1st degree relative, or non-glaucoma related optic neuropathy in both eyes.
- Retinal vein or artery occlusions in both eyes (branch or central).
- Active or history of proliferative diabetic retinopathy, or diabetic papillitis in both eyes.
- Symptoms and/or signs that, in the opinion of the investigator, indicate possible raised intracranial pressure.
- Current or previous history of disorders affecting intracranial pressure including, but not limited to, idiopathic intracranial hypertension, hydrocephalus, epilepsy, intracranial bleeds, space occupying lesions or tumours, traumatic brain injury, central nervous system inflammatory or infectious disorders, congenital neuro-cranial disorders, neurosurgical or interventional procedures. Radiologically-confirmed ischaemic stroke is permissible, provided the patient did not develop a subsequent haemorrhagic stroke or require neurosurgical intervention.
- Current or recent (6 months) history of medication use affecting intracranial pressure including steroids, vitamin A analogues, tetracyclines, recombinant growth hormone, lithium, nitrofurantoin, nalidixic acid, sulfenazone, cyclosporine, amiodarone.
- Bed-bound patients.
- Patients who, in the opinion of the investigator, would be unwilling or unable to provide written informed consent, or undergo the testing procedures as described in the protocol.
- Patients due to undergo lumbar puncture or intracranial pressure bolt monitoring:
- Aged ≥18 years.
- Patients due to undergo lumbar puncture with measurement of Opening and Closing CSF pressures
- Patients due to undergo continuous ICP monitoring
- \. Current or previous evidence of glaucoma or glaucoma suspect in both eyes.
- \. Retinal vein or artery occlusions in both eyes (branch or central).
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Hospital NHS Trustlead
- King's College Londoncollaborator
Study Sites (1)
King's Ophthalmology Research Unit
London, London, SE5 9RS, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2025
First Posted
March 3, 2025
Study Start
January 10, 2025
Primary Completion
November 30, 2025
Study Completion
November 30, 2025
Last Updated
August 3, 2025
Record last verified: 2025-01